Joint Commission launches Medication Compounding Certification

Editor's Note

The Joint Commission on February 21 launched a Medication Compounding Certification that addresses new medication compounding laws and regulations.

The certification, which is awarded for a 2-year period, was developed in collaboration with the United States Pharmacopeial Convention (USP) to help healthcare organizations ensure compliance with Joint Commission and USP standards, including those related to the process, testing, and verification of compounded sterile and nonsterile preparations.

View the multimedia news release Across the United States, patient safety and quality events related to medication compounding have led many state legislatures and boards of pharmacy to enhance and strengthen regulations. To support health care organizations in complying with these requirements, The Joint Commission has developed a new Medication Compounding Certification program.